3rd Quarter - Termination
LENT SCRIVNER & ROTH LLC for AMGEN INC
Client
Income
$20,000
Expenses
—
Terminated
Jul 31, 2008
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Biosimilars Legislation HR 1038 - Access to Life Savings Medicine Act HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 FDA Drug Safety Oversight
| Lobbyist | Covered position, as disclosed |
|---|---|
| NORMAN LENT | — |
| PETE LEON | Legislative Director for Rep. Eliot Engel |
| RICHARD MOLEN | — |
| MICHAEL SCRIVNER | — |
Medicare/Medicaid MMM
Medicare Coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| NORMAN LENT | — |
| PETE LEON | Legislative Director for Rep. Eliot Engel |
| RICHARD MOLEN | — |
| MICHAEL SCRIVNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.